CD44 and head and neck squamous cell carcinoma: A preclinical model in head and neck squamous cell carcinoma (HNSCC) demonstrated that CD44+ cells have significantly increased PD-L1 expression, both constitutive and inducible, in comparison with their CD44- counterparts [24].